NEOGENOMICS INC 8K

NeoGenomics appointed Carolyn Starrett to its Board of Directors to bolster its expertise in AI-driven oncology diagnostics.

On June 25, 2026, NeoGenomics, Inc. announced that it has appointed Carolyn Starrett, a seasoned healthcare data and technology executive and former CEO and Board Director of Flatiron Health, to its Board of Directors, adding expertise in AI, real-world data, and oncology insights to support the company’s strategic initiatives and portfolio expansion in cancer diagnostics.

Filing Facts

CIK

1077183

Ticker

-

Form

8K

Source Type

sec

Accession

0001628280-26-045350

Alert Tier

5